Roche Drug Reduces Need for Ventilation in Covid Patients

(Bloomberg) -- Roche Holding AG said its Actemra drug reduced the need for ventilation in a third-phase clinical trial on hospitalized patients with Covid-19 and pneumonia.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.